Rotaxane-type probe for molecular imaging

US11045561B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11045561-B2
Application numberUS-201815939261-A
CountryUS
Kind codeB2
Filing dateMar 28, 2018
Priority dateMar 28, 2017
Publication dateJun 29, 2021
Grant dateJun 29, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a novel method for synthesizing hyperpolarized xenon-129 (HP Xe) biosensors by using pseudo-rotaxane structures of gamma-cyclodextrin. These supramolecular complexes form novel ternary structures in the presence of HP Xe which can be detected via 129 Xe MR spectroscopy and imaging techniques. The rotaxane-type complex can be tagged with an affinity label for detecting a target in a biological subject.

First claim

Opening claim text (preview).

What is claimed is: 1. A supramolecular complex useful as a biosensor, comprising: (a) a macrocycle host defining a hydrophobic cavity; (b) an axle comprising a molecular chain functionalized with an affinity tag for a target inside a biological subject, wherein the affinity tag is at one or both ends of the molecular chain, and wherein the axle is threaded through the macrocycle cavity; and (c) a xenon atom, wherein the cavity of the macrocycle host is large enough to accommodate and reversibly encapsulate both a cross section of the axle and the xenon atom at the same time. 2. The supramolecular complex of claim 1 , wherein the macrocycle host is water-soluble. 3. The supramolecular complex of claim 1 , wherein the xenon atom is dissolved in a solution. 4. The supramolecular complex of claim 1 , wherein the macrocycle host defines a cavity that is larger than about 6.5 Å in inner diameter. 5. The supramolecular complex of claim 1 , wherein the macrocycle host is a cyclodextrin. 6. The supramolecular complex of claim 5 , wherein the macrocycle host is a γ-cyclodextrin. 7. The supramolecular complex of claim 1 , wherein the axle comprises an alkyl chain. 8. The supramolecular complex of claim 7 , wherein the axle has at least five carbons in its backbone. 9. The supramolecular complex of claim 1 , wherein the axle is capped with a hydrophobic end group at each of its two ends, at least one of the end groups being or comprising the affinity tag. 10. The supramolecular complex of claim 1 , wherein the affinity tag comprises a ligand selected for its affinity for a biological target inside a subject. 11. The supramolecular complex of claim 1 , wherein the affinity tag comprises a detectable label. 12. The supramolecular complex of claim 11 , wherein the affinity tag comprises a fluorophore. 13. The supramolecular complex of claim 1 , wherein the affinity tag comprises thioflavin T. 14. The supramolecular complex of claim 1 , detectable by xenon-based magnetic resonance imaging or spectroscopy. 15. A biosensor comprising: (a) a cyclodextrin molecule defining a cavity; (b) an alkyl chain molecule functionalized with an affinity tag at one or each of its two ends, wherein the affinity tag has an affinity for a target inside a biological subject, and wherein the alkyl chain molecule is threaded through the cavity in the cyclodextrin; and (c) a xenon atom in the cavity of the cyclodextrin. 16. The biosensor of claim 15 , wherein the affinity tag comprises a detectable label. 17. The biosensor of claim 15 , wherein the affinity tag is part of an end group that also serves as a stopper to prevent de-threading. 18. The biosensor of claim 17 , wherein the end group is hydrophobic. 19. The biosensor of claim 17 , wherein the end group comprises an ethylimidazolium group or an anthracene group. 20. The biosensor of claim 15 , wherein the xenon atom is xenon-129.

Assignees

Inventors

Classifications

  • Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes · CPC title

  • Compositions of unspecified macromolecular compounds · CPC title

  • Polyrotaxanes; Polycatenanes · CPC title

  • with fluorescent label · CPC title

  • involving the use of a carrier gas for transport to the sensor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11045561B2 cover?
The invention provides a novel method for synthesizing hyperpolarized xenon-129 (HP Xe) biosensors by using pseudo-rotaxane structures of gamma-cyclodextrin. These supramolecular complexes form novel ternary structures in the presence of HP Xe which can be detected via 129 Xe MR spectroscopy and imaging techniques. The rotaxane-type complex can be tagged with an affinity label for detecting a …
Who is the assignee on this patent?
Rhode Island Council On Postsecondary Education, Univ Of Rhode Island Board Of Trustees
What technology area does this patent fall under?
Primary CPC classification C08B37/0015. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).